{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:50:15Z","timestamp":1786985415342,"version":"build-2736575974"},"reference-count":90,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["bloodreviews.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.blre.2014.02.001","type":"journal-article","created":{"date-parts":[[2014,3,8]],"date-time":"2014-03-08T21:47:34Z","timestamp":1394315254000},"page":"87-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["The pathogenesis and treatment of large granular lymphocyte leukemia"],"prefix":"10.1016","volume":"28","author":[{"given":"Steven Nathaniel","family":"Steinway","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"LeBlanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Thomas P.","family":"Loughran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2014.02.001_bb0005","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1182\/blood-2010-07-296962","article-title":"How I treat LGL leukemia","volume":"117","author":"Lamy","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.02.001_bb0010","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.3109\/10428194.2011.593276","article-title":"T-cell and natural killer-cell large granular lymphocyte leukemia neoplasias","volume":"52","author":"Watters","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2014.02.001_bb0015","first-page":"186","article-title":"Activation-induced cell death in T cells and autoimmunity","volume":"1","author":"Zhang","year":"2004","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.blre.2014.02.001_bb0020","doi-asserted-by":"crossref","first-page":"169","DOI":"10.7326\/0003-4819-102-2-169","article-title":"Leukemia of large granular lymphocytes: association with clonal chromosomal abnormalities and autoimmune neutropenia, thrombocytopenia, and hemolytic anemia","volume":"102","author":"Loughran","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.blre.2014.02.001_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V82.1.1.bloodjournal8211","article-title":"Clonal diseases of large granular lymphocytes","volume":"82","author":"Loughran","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.02.001_bb0030","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","article-title":"World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997","volume":"17","author":"Harris","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2014.02.001_bb0035","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.blre.2014.02.001_bb0040","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1182\/blood.V84.7.2315.2315","article-title":"CD3+, CD56+ aggressive variant of large granular lymphocyte leukemia","volume":"84","author":"Gentile","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.02.001_bb0045","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ajh.20853","article-title":"Aggressive T-cell large granular lymphocyte leukemia: a case report and review of the literature","volume":"82","author":"Alekshun","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2014.02.001_bb0050","first-page":"1514","article-title":"Aggressive acute CD3+, CD56- T cell large granular lymphocyte leukemia with two stages of maturation arrest","volume":"10","author":"Tordjman","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2014.02.001_bb0055","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1182\/blood.V87.4.1474.bloodjournal8741474","article-title":"Natural killer-like T-cell lymphomas: aggressive lymphomas of T-large granular lymphocytes","volume":"87","author":"Macon","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.02.001_bb0060","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/107327489800500103","article-title":"Large Granular Lymphocyte Leukemia","volume":"5","author":"Lamy","year":"1998","journal-title":"Cancer Control"},{"key":"10.1016\/j.blre.2014.02.001_bb0065","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/0046-8177(94)90018-3","article-title":"Epstein-Barr virus-associated natural killer-large granular lymphocyte leukemia","volume":"25","author":"Gelb","year":"1994","journal-title":"Hum Pathol"},{"key":"10.1016\/j.blre.2014.02.001_bb0070","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/blood-2011-10-381921","article-title":"EBV-associated T\/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases","volume":"119","author":"Kimura","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.02.001_bb0075","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1182\/blood.V95.10.3219","article-title":"Chronic neutropenia mediated by fas ligand","volume":"95","author":"Liu","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.02.001_bb0080","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.blre.2006.01.003","article-title":"Pathogenesis of neutropenia in large granular lymphocyte leukemia and Felty syndrome","volume":"20","author":"Burks","year":"2006","journal-title":"Blood Rev"},{"key":"10.1016\/j.blre.2014.02.001_bb0085","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1182\/blood.V84.5.1620.1620","article-title":"Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance?","volume":"84","author":"Dhodapkar","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.02.001_bb0090","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1136\/jcp.51.9.672","article-title":"Association of pure red cell aplasia with T large granular lymphocyte leukaemia","volume":"51","author":"Kwong","year":"1998","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.blre.2014.02.001_bb0095","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1365-2141.2001.02561.x","article-title":"Coincident myelodysplastic syndrome and T-cell large granular lymphocytic disease: clinical and pathophysiological features","volume":"112","author":"Saunthararajah","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2014.02.001_bb0100","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.3324\/haematol.2009.018481","article-title":"Analysis of a French cohort of patients with large granular lymphocyte leukemia: a report on 229 cases","volume":"95","author":"Bareau","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2014.02.001_bb0105","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1182\/blood.V92.12.4771","article-title":"Dysregulation of CD95\/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia","volume":"92","author":"Lamy","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.02.001_bb0110","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1182\/blood-2007-06-093823","article-title":"Antigen activation and impaired Fas-induced death-inducing signaling complex formation in T-large-granular lymphocyte leukemia","volume":"111","author":"Yang","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.02.001_bb0115","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1182\/blood.V100.4.1449.h81602001449_1449_1453","article-title":"Blockade of Fas-dependent apoptosis by soluble Fas in LGL leukemia","volume":"100","author":"Liu","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.02.001_bb0120","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1359-6101(02)00029-1","article-title":"Regulation of lymphoid homeostasis by interleukin-15","volume":"13","author":"Lodolce","year":"2002","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.blre.2014.02.001_bb0125","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1158\/0008-5472.CAN-08-3735","article-title":"Interleukin-15 enhances proteasomal degradation of bid in normal lymphocytes: implications for large granular lymphocyte leukemias","volume":"69","author":"Hodge","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.blre.2014.02.001_bb0130","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1172\/JCI43242","article-title":"NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and human","volume":"121","author":"Yu","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2014.02.001_bb0135","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1182\/blood-2012-08-450585","article-title":"Phase 1 trial of IL-15 trans presentation blockade using humanized Mikbeta1 mAb in patients with T-cell large granular lymphocytic leukemia","volume":"121","author":"Waldmann","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.02.001_bb0140","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1586\/eci.13.28","article-title":"Targeting IL-15 in large granular lymphocyte leukemia","volume":"9","author":"Steinway","year":"2013","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.blre.2014.02.001_bb0145","doi-asserted-by":"crossref","first-page":"16308","DOI":"10.1073\/pnas.0806447105","article-title":"Network model of survival signaling in large granular lymphocyte leukemia","volume":"105","author":"Zhang","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2014.02.001_bb0150","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1182\/blood-2009-06-223719","article-title":"Platelet-derived growth factor mediates survival of leukemic large granular lymphocytes via an autocrine regulatory pathway","volume":"115","author":"Yang","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.02.001_bb0155","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1038\/sj.onc.1210421","article-title":"MAP kinase signalling pathways in cancer","volume":"26","author":"Dhillon","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.blre.2014.02.001_bb0160","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1182\/blood-2010-02-271080","article-title":"Targeting of survivin by nanoliposomal ceramide induces complete remission in a rat model of NK-LGL leukemia","volume":"116","author":"Liu","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.02.001_bb0165","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1038\/sj.onc.1208122","article-title":"ERK couples chronic survival of NK cells to constitutively activated Ras in lymphoproliferative disease of granular lymphocytes (LDGL)","volume":"23","author":"Epling-Burnette","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.blre.2014.02.001_bb0170","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1535-6108(03)00248-4","article-title":"Targeting the PI3K-Akt pathway in human cancer: rationale and promise","volume":"4","author":"Luo","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.blre.2014.02.001_bb0175","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrc839","article-title":"The phosphatidylinositol 3-Kinase AKT pathway in human cancer","volume":"2","author":"Vivanco","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.blre.2014.02.001_bb0180","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1182\/blood-2005-08-3076","article-title":"Phosphatidylinositol-3-phosphate kinase pathway activation protects leukemic large granular lymphocytes from undergoing homeostatic apoptosis","volume":"107","author":"Schade","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.02.001_bb0185","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1182\/blood-2007-11-121871","article-title":"Molecular profiling of LGL leukemia reveals role of sphingolipid signaling in survival of cytotoxic lymphocytes","volume":"112","author":"Shah","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.02.001_bb0190","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1182\/blood-2011-01-331447","article-title":"Therapeutic efficacy of FTY720 in a rat model of NK-cell leukemia","volume":"118","author":"Liao","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.02.001_bb0195","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1172\/JCI9940","article-title":"Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression","volume":"107","author":"Epling-Burnette","year":"2001","journal-title":"J Clin Invest"},{"issue":"S1","key":"10.1016\/j.blre.2014.02.001_bb0200","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1182\/blood-2012-07-441378","article-title":"Intrinsic and extrinsic mechanisms contribute to maintain the JAK\/STAT pathway aberrantly activated in T-type large granular lymphocyte leukemia","volume":"121","author":"Teramo","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.02.001_bb0205","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1114885","article-title":"Somatic STAT3 mutations in large granular lymphocytic leukemia","volume":"366","author":"Koskela","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2014.02.001_bb0210","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1182\/blood-2012-06-435297","article-title":"STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia","volume":"120","author":"Jerez","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.02.001_bb0215","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1182\/blood-2013-04-494930","article-title":"STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patients","volume":"122","author":"Jerez","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.02.001_bb0220","first-page":"2595","article-title":"Results of a prospective multicenter phase II study of initial treatment with methotrexate in LGL leukemia (ECOG protocol E5998)","volume":"116","author":"Thomas","year":"2010"},{"key":"10.1016\/j.blre.2014.02.001_bb0225","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1182\/blood-2012-12-474577","article-title":"Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia","volume":"121","author":"Rajala","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.02.001_bb0230","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1054\/blre.1999.0118","article-title":"Current concepts: large granular lymphocyte leukemia","volume":"13","author":"Lamy","year":"1999","journal-title":"Blood Rev"},{"key":"10.1016\/j.blre.2014.02.001_bb0235","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/1097-0142(19900115)65:2<341::AID-CNCR2820650227>3.0.CO;2-2","article-title":"Clinical course and prognosis of the lymphoproliferative disease of granular lymphocytes. A multicenter study","volume":"65","author":"Pandolfi","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.blre.2014.02.001_bb0240","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2141.2007.06564.x","article-title":"The expression of the novel cytotoxic protein granzyme M by large granular lymphocytic leukaemias of both T-cell and NK-cell lineage: an unexpected finding with implications regarding the pathobiology of these disorders","volume":"137","author":"Morice","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2014.02.001_bb0245","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2559.2007.02656.x","article-title":"Characteristic appearances of the bone marrow in T-cell large granular lymphocyte leukaemia","volume":"50","author":"Osuji","year":"2007","journal-title":"Histopathology"},{"key":"10.1016\/j.blre.2014.02.001_bb0250","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1309\/PH7X78HF4FW4PRKW","article-title":"T-cell large granular lymphocyte leukemias have multiple phenotypic abnormalities involving pan-T-cell antigens and receptors for MHC molecules","volume":"124","author":"Lundell","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.blre.2014.02.001_bb0255","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1182\/blood-2002-08-2408","article-title":"Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94:NKG2C\/E and NKD2D killer cell receptors","volume":"101","author":"Bigouret","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.02.001_bb0260","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","article-title":"Central memory and effector memory T cell subsets: function, generation, and maintenance","volume":"22","author":"Sallusto","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.blre.2014.02.001_bb0265","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/sj.leu.2404112","article-title":"TCRgammadelta+large granular lymphocyte leukemias reflect the spectrum of normal antigen-selected TCRgammadelta+T-cells","volume":"20","author":"Sandberg","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2014.02.001_bb0270","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.leukres.2007.04.011","article-title":"Clinical spectrum of gammadelta+T cell LGL leukemia: analysis of 20 cases","volume":"32","author":"Bourgault-Rouxel","year":"2008","journal-title":"Leuk Res"},{"key":"10.1016\/j.blre.2014.02.001_bb0275","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1182\/blood.V98.1.165","article-title":"Molecular and flow cytometric analysis of the Vbeta repertoire for clonality assessment in mature TCRalphabeta T-cell proliferations","volume":"98","author":"Langerak","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.02.001_bb0280","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0002-9440(10)63032-5","article-title":"Immunophenotypic analysis of the TCR-Vbeta repertoire in 98 persistent expansions of CD3(+)\/TCR-alphabeta(+) large granular lymphocytes: utility in assessing clonality and insights into the pathogenesis of the disease","volume":"159","author":"Lima","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.blre.2014.02.001_bb0285","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1182\/blood.V87.6.2369.bloodjournal8762369","article-title":"The natural killer-related receptor for HLA-C expressed on T cells from CD3+ lymphoproliferative disease of granular lymphocytes displays either inhibitory or stimulatory function","volume":"87","author":"Cambiaggi","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.02.001_bb0290","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/hon.777","article-title":"Skewed expression of natural-killer (NK)-associated antigens on lymphoproliferations of large granular lymphocytes (LGL)","volume":"24","author":"Fischer","year":"2006","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.blre.2014.02.001_bb0295","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1182\/blood-2003-02-0400","article-title":"Dysregulated NK receptor expression in patients with lymphoproliferative disease of granular lymphocytes","volume":"103","author":"Epling-Burnette","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.02.001_bb0300","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/sj.leu.2404634","article-title":"Genotypic evaluation of killer immunoglobulin-like receptors in NK-type lymphoproliferative disease of granular lymphocytes","volume":"21","author":"Scquizzato","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2014.02.001_bb0305","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1634\/theoncologist.9-3-247","article-title":"T-cell large granular lymphocyte leukemia and related disorders","volume":"9","author":"Rose","year":"2004","journal-title":"Oncologist"},{"key":"10.1016\/j.blre.2014.02.001_bb0310","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1046\/j.1365-2141.1998.00712.x","article-title":"Large granular lymphocyte leukaemia occurring after renal transplantation","volume":"101","author":"Gentile","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2014.02.001_bb0315","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/ajh.2830490307","article-title":"T-cell large granular lymphocytic leukemia following orthotopic liver transplantation","volume":"49","author":"Feher","year":"1995","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2014.02.001_bb0320","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1309\/VA755A03PVRV9XDT","article-title":"T-cell large granular lymphocyte leukemia of donor origin after allogeneic bone marrow transplantation","volume":"120","author":"Au","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.blre.2014.02.001_bb0325","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1309\/GLH5NVCFB9BKMV9G","article-title":"T-cell large granular lymphocytic leukemia of donor origin occurring after allogeneic bone marrow transplantation for B-cell lymphoproliferative disorders","volume":"123","author":"Chang","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.blre.2014.02.001_bb0330","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/bmt.2013.5","article-title":"Large granular lymphocytosis and its impact on long-term clinical outcomes following allo-SCT","volume":"48","author":"Kim","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2014.02.001_bb0335","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/MOH.0b013e32834760fb","article-title":"The spectrum of large granular lymphocyte leukemia and Felty's syndrome","volume":"18","author":"Liu","year":"2011","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.blre.2014.02.001_bb0340","first-page":"365","article-title":"Epstein-Barr virus and rheumatoid arthritis","volume":"65","author":"Bonneville","year":"1998","journal-title":"Rev Rhum"},{"key":"10.1016\/j.blre.2014.02.001_bb0345","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1056\/NEJM199912303412707","article-title":"Molecular mimicry and autoimmunity","volume":"341","author":"Albert","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2014.02.001_bb0350","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1309\/A8FHDA0VVRJ05GJP","article-title":"T-cell large granular leukemia and related proliferations","volume":"127","author":"O'Malley","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.blre.2014.02.001_bb0355","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1182\/blood.V84.7.2164.2164","article-title":"Treatment of large granular lymphocyte leukemia with oral low-dose methotrexate","volume":"84","author":"Loughran","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.02.001_bb0360","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/cncr.22032","article-title":"T-cell large granular lymphocyte leukemia: a report on the treatment of 29 patients and a review of the literature","volume":"107","author":"Osuji","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.blre.2014.02.001_bb0365","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1182\/blood.V98.2.483","article-title":"Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes","volume":"98","author":"Go","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.02.001_bb0370","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3324\/haematol.12871","article-title":"Long-term responses and outcomes following immunosuppressive therapy in large granular lymphocyte leukemia-associated pure red cell aplasia: a Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group","volume":"93","author":"Fujishima","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2014.02.001_bb0375","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1046\/j.1365-2141.1996.5061047.x","article-title":"Cyclosporine A alleviates severe anaemia associated with refractory large granular lymphocytic leukaemia and chronic natural killer cell lymphocytosis","volume":"93","author":"Bible","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2014.02.001_bb0380","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1182\/blood.V91.9.3372","article-title":"Neutropenia associated with T-cell large granular lymphocyte leukemia: long-term response to cyclosporine therapy despite persistence of abnormal cells","volume":"91","author":"Sood","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.02.001_bb0385","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1046\/j.1365-2141.2003.04613.x","article-title":"HLA-DR4 predicts haematological response to cyclosporine in T-large granular lymphocyte lymphoproliferative disorders","volume":"123","author":"Battiwalla","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2014.02.001_bb0390","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.leukres.2006.09.003","article-title":"T-cell large granular lymphocytic (T-LGL) leukemia: experience in a single institution over 8years","volume":"31","author":"Aribi","year":"2007","journal-title":"Leuk Res"},{"key":"10.1016\/j.blre.2014.02.001_bb0395","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/MOH.0b013e32831c8407","article-title":"Diagnosis and therapy of neutropenia in large granular lymphocyte leukemia","volume":"16","author":"Mohan","year":"2009","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.blre.2014.02.001_bb0400","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1046\/j.1365-2141.2003.04148.x","article-title":"Neutropenia and anaemia associated with T-cell large granular lymphocyte leukaemia responds to fludarabine with minimal toxicity","volume":"120","author":"Sternberg","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2014.02.001_bb0405","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1365-2141.2004.04852.x","article-title":"Fludarabine, mitoxantrone and dexamethasone in the treatment of indolent B- and T-cell lymphoid malignancies in Chinese patients","volume":"124","author":"Ma","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2014.02.001_bb0410","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1038\/sj.leu.2404767","article-title":"Fludarabine, mitoxantrone and dexamethasone as first-line treatment for T-cell large granular lymphocyte leukemia","volume":"21","author":"Tse","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2014.02.001_bb0415","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3109\/10428191003706947","article-title":"Large granular lymphocyte leukemia: natural history and response to treatment","volume":"51","author":"Fortune","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2014.02.001_bb0420","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1046\/j.1365-2141.2003.04609.x","article-title":"Successful treatment of refractory pure red cell aplasia associated with lymphoproliferative disorders with the anti-CD52 monoclonal antibody alemtuzumab (Campath-1H)","volume":"123","author":"Ru","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2014.02.001_bb0425","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1182\/blood-2003-11-3951","article-title":"Efficacy of alemtuzumab treatment for refractory T-cell large granular lymphocytic leukemia","volume":"103","author":"Rosenblum","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.02.001_bb0430","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.leukres.2005.02.018","article-title":"Alemtuzumab induced complete remission of therapy-resistant pure red cell aplasia","volume":"29","author":"Au","year":"2005","journal-title":"Leuk Res"},{"key":"10.1016\/j.blre.2014.02.001_bb0435","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1038\/sj.leu.2403956","article-title":"Remission of pure red cell aplasia in T-cell receptor gammadelta-large granular lymphocyte leukemia after therapy with low-dose alemtuzumab","volume":"19","author":"Schutzinger","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2014.02.001_bb0440","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1200\/JCO.2009.22.6688","article-title":"Phase II study of alemtuzumab in combination with pentostatin in patients with T-cell neoplasms","volume":"27","author":"Ravandi","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2014.02.001_bb0445","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/j.leukres.2010.01.019","article-title":"Rapid and durable molecular response of refractory T-cell large granular lymphocyte leukemia after alemtuzumab treatment","volume":"34","author":"Monjanel","year":"2010","journal-title":"Leuk Res"},{"key":"10.1016\/j.blre.2014.02.001_bb0450","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s12032-009-9206-z","article-title":"T-cell large granular lymphocytic (T-LGL) leukemia: a single institution experience","volume":"27","author":"Sretenovic","year":"2010","journal-title":"Med Oncol"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X14000150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X14000150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T00:21:03Z","timestamp":1597537263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X14000150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":90,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0268960X14000150"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2014.02.001","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The pathogenesis and treatment of large granular lymphocyte leukemia","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2014.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}